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Abstract  
 
Iron deficiency is relatively common in pregnancy and has both short and long term 
consequences. However, little is known about the effect on the metabolism of other 
micronutrients. 54 female rats were fed control (50 mg iron/ kg) or iron deficient diets (7.5 mg 
/ kg) prior to and during pregnancy. Maternal liver, placenta and fetal liver were collected at 
day 21 of pregnancy for copper and zinc analysis, and to measure expression of the major genes 
of copper and zinc metabolism. Copper levels increased in the maternal liver (p = 0.002) and 
placenta (p = 0.018) of iron deficient rats. zinc increased (p < 0.0001) and copper decreased (p 
= 0.006) in the fetal liver. Hepatic expression of the copper chaperones ATOX1 (p = 0.042) 
and COX17 (p = 0.020) decreased in the iron deficient dams, while the expression of the genes 
of zinc metabolism was unaltered. In the placenta, iron deficiency reduced the expression of 
the chaperone for SOD1, CCS (p = 0.030), ceruloplasmin (p = 0.042), and zinc transport genes, 
ZIP4 (p = 0.047) and ZnT1 (p = 0.012). In fetal liver, iron deficiency increased COX17 (p = 
0.020), ZIP14 (p = 0.036) and ZnT1 (p = 0.0003), and decreased ZIP4 (p = 0.004). The results 
demonstrate that iron deficiency during pregnancy has opposite effects on copper and zinc 
levels in the fetal liver. This may, in turn, alter metabolism of these nutrients, with 
consequences for development in the fetus and neonate.  
 
  
1 Introduction 
 
Iron deficiency is the most common nutrient deficiency worldwide and is particularly prevalent 
in children, women of child bearing age and pregnant women. Even in the UK, it is estimated 
that 23% of women aged 19-64 and nearly half of teenage girls do not reach their lower 
reference nutrient intake for iron (1). During development, the fetus relies entirely on maternal 
supply for iron, zinc and copper, which are critical for development and health. Crosstalks 
between these three trace elements have been established decades ago (2-4) but the effect of iron 
deficiency on the metabolism of copper and zinc is still not fully understood, particularly during 
pregnancy. The ability to carry out work establishing these links is, of course, limited, but 
micronutrient metabolism is well conserved in mammals, and the rat has been shown to be a 
very good model for pregnancy and nutrition in humans (3).   
Generally, iron deficiency in mammals results in increased copper levels in the blood, gut and 
liver (5-7). Circulating ceruloplasmin (CP), produced by the liver, and its gut homolog 
hephaestin, are copper dependent ferroxidases and appear as an evident link between iron and 
copper metabolism. Accordingly, iron deficiency in rats induces an increase in serum copper 
associated with an increase in CP levels (5). Interestingly, iron deficient rats have higher liver 
copper levels which correlate with CP expression and its ferroxidase activity, while hepatic CP 
mRNA remains unchanged, suggesting that copper loading is associated with an increased 
metallation of the protein (8) . Iron deficiency also increases the expression of the Menkes 
copper ATPase (ATP7a) in the duodenum (6, 9), suggesting an increased export of copper from 
the enterocyte to the circulation, while Wilson copper ATPase (ATP7b) expression in the liver 
is unaltered (6). In addition, copper and iron may compete for DMT1 for their uptake in the gut. 
Although copper influx through DMT1 in the enterocyte is minor compared to CTR1 in replete 
conditions, it is of particular importance during iron deficiency, due to its upregulation and the 
lack of iron in the lumen, which favours copper uptake (10).  
The effect of iron deficiency on zinc status is believed to be less important than on copper 
status. Iron deficiency appears to reduce zinc requirements in rats, increasing zinc levels in 
several organs such as liver, spleen, brain or kidney (11, 12), while decreasing apparent zinc 
absorption (13)  and plasma zinc (14). Noteworthy, marginal iron deficiency (9 and 13 mg iron 
per kg diet) did not affect zinc status in rat, while it was sufficient to induce copper 
accumulation in the liver (15). Because iron and zinc have similar mechanisms of absorption 
and transport in the gut, they were originally thought to compete with each other, notably 
through DMT1. Accordingly, iron treatment reduces the transport of zinc in Caco-2 cells, 
although to a lesser extent than other divalent cations (16). However, DMT1’s affinity for zinc 
is much lower than for iron and its contribution to zinc transport and uptake is probably 
minimal(17).  
Two families of zinc transporters have been identified, ZIP and ZnT, generally involved in 
influx and efflux of the cells, respectively. ZIP stands for Zrt (zinc regulated transporter), Irt 
(iron regulated transporter)-like protein, and is composed of 14 members in mammals. They 
are characterised by their ability to transport zinc, but several of them have also been reported 
to mediate the uptake of iron, as well as manganese (18). In rats, iron overload increases the 
expression of several ZIPs in the liver, namely ZIP5 (up), ZIP6, ZIP7 and ZIP10 (down), while 
ZIP14, the most abundant ZIP in the liver, is upregulated by iron deficiency (19). On the other 
hand, the ZnT (zinc transporters) family comprises 10 members so far, and contribute to zinc 
homeostasis by exporting zinc out of the cell or sequestrating zinc into cellular compartments 
when zinc levels are low. While there is evidence of direct action of iron on ZIP, which may 
lead to alterations of zinc metabolism, interactions between iron and ZnT have not been 
identified.  
Metabolic crossroads between iron, copper and zinc during pregnancy are less known. 
Maternal iron deficiency in rat increases copper levels in the maternal liver, maternal serum, 
as well as the placenta (20, 21) along with an increase in serum copper and ceruloplasmin (22) . In 
contrast, we showed that iron deficiency decreased copper levels in the fetal liver, without 
affecting the fetal expression of the main genes involved in copper metabolism (23, 24). In 
humans, iron supplementation has been shown to decrease plasma zinc levels during pregnancy 
and zinc absorption during lactation in humans (25-27). Whether iron deficiency, as opposed to 
overload, affects zinc metabolism in the mother and fetus remains essentially unknown. In this 
study we investigated the effect of maternal iron deficiency on zinc status in pregnant rats and 
the offspring, as well as the implication of major genes of zinc metabolism. We also examined 
the mechanisms through which iron deficiency differentially affects copper metabolism in the 
mother and fetus and tested the implication of most genes of copper metabolism in the liver of 
the mother and fetus, as well as in the placenta.  
2 Material and methods 
2.1 Animal procedures 
Experiments were performed using female Rowett Hooded rats from 3 different studies of 
identical design. The protocol and animal procedures have recently been described in detail (28) 
and were approved by the Rowett Institute Ethics Committees and conducted in accordance 
with the UK Animals (Scientific Procedures) Act 1986. Briefly, 54 weanling females were fed 
a control diet (AIN93, containing 860 mg/kg Zn and 170 mg/kg Cu) for 2 weeks and were then 
randomised into two groups. 30 remained on the control diet (Fe = 50mg/kg) for 4 weeks until 
mating and 24 switched to an iron deficient (Fe = 7.5 mg/kg) diet for the same duration. They 
were mated with males of the same strain and remained on the same diet until they were killed 
at day 21 of gestation. Dams were killed by stunning and cervical dislocation and the fetuses 
by decapitation. Animals were housed under 12;12 light dark cycle with a constant temperature 
(22 oC). No adverse effects were recorded as a result of this dietary intervention. 
Livers from the dams and fetuses, as well as the placentas, were collected and immediately 
frozen in liquid nitrogen. They were kept in metal free vials and stored at -80°C until analysis. 
Whenever possible, placentas and fetal livers from the 3 male median weights in each litter 
were pooled together and ground in liquid nitrogen. Ground tissues from maternal liver, pooled 
placentas and pooled fetal livers were used for iron, copper and zinc content (control n = 24, 
iron deficient n = 30) and gene analysis (control n = 21, iron deficient n = 24). It should be 
noted that control and iron deficient samples from each of the three animal studies were 
analysed together, and results from each experiment were then pooled together for data 
analysis. 
2.2 Assessment of copper and zinc status 
Total copper and zinc were measured in maternal liver, placenta and fetal liver by inductively 
coupled plasma mass spectrometry (ICP-MS) as previously described (28). Samples were 
digested in 2 % HNO3, 0.5% HCl, and metal concentrations measured using an Agilent 7700X 
spectrophotometer (Agilent Technologies) equipped with a MicroMist nebulizer, nickel 
sampler and skimmer cones. Intra-assay CV% were 10.8% (Fe), 11.1% (Cu) and 5.2% (Zn). 
2.3 RNA extraction and real-time RT-qPCR 
20-30 mg of frozen placenta, maternal and fetal liver ground tissue was homogenized after 
grinding, using a T25 Ultra-Turrax ®. RNA was isolated with the RNeasy ® Mini Kit (Qiagen) 
and 200 ng were reverse transcribed on a PTC-100® Thermal Cycler (Bio-Rad Laboratories, 
Hemel Hempstead, UK) using the Applied Biosystems® TaqMan® RT reagent kit (Life 
technologies, Paisley, UK). cDNA fragments were amplified by real-time qPCR (7700 
Sequence detection system, Life technologies) using the primers (TaqMan®, ThermoFisher 
Scientific) described in Table 1. The most relevant genes of copper (24) and zinc metabolism 
were selected. Specifically, ZIP-1 is ubiquitously expressed and was shown to bind iron with 
high affinity (29). ZIP-4 is crucial during development and for the absorption of maternal zinc 
(30). ZIP8 and 14 are closely related and have both been shown to mediate iron transport in 
addition to zinc (31, 32). ZnT-1 (ubiquitous), ZnT-4 and ZnT-5 are sensitive to maternal zinc 
status and may play an important role in fetal zinc supply from the maternal diet (33, 34) . The 
gene expression was normalized to 18s rRNA (HS99999901_s1) in all samples. This was 
chosen even though the levels of expression were higher than the test genes because it was 
which was the only gene that was consistently unaffected by the nutritional treatments 
(Roussel, G, McArdle, HJ, unpublished data). 
The experiment was performed and data interpreted according to the Minimum Information for 
Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines (35): 18sRNA 
expression did not significantly vary between the iron deficient and control groups in all tissues 
(Mann-Whitney test, data not shown). Linear amplification was observed for 18s and all genes 
of interest across their range of expression. 
 
2.4 Statistical analysis 
Iron, copper and zinc content are expressed in μg/g dry tissue. The material used in this paper 
were obtained from 3 separate experiments. To minimize variations between the three animal 
studies, as well as between each PCR run, the expression of copper and zinc genes was 
expressed as percentage of the average gene expression of the control group for each of the 3 
experiments. The normality of the distribution and equality of variances were analysed with 
GraphPad Prism (version 5.04). Data were analysed with IBM SPSS statistics 21.0 software 
using unpaired t-tests when data were normally distributed and otherwise using non-
parametrical tests (Mann-Whitney U). 
 
  
3 Results 
3.1 Copper and Zinc levels 
The effect of maternal iron deficiency on growth, placental:fetal ratio, placenta and liver 
weights, hematocrit and iron levels in this study has been recently reported (28). Specifically, 
iron levels were decreased by 152.6 μg/g (~ -30%), 604.0 μg/g (~ -60%) and 369.4 μg/g dry 
tissue (~ -75%), in the placenta, fetal and maternal liver, respectively (28). Maternal liver and 
placenta weight were not affected by iron deficiency while fetal weight and fetal liver weight 
were significantly decreased by ~13% and ~25%, respectively (28). Maternal iron deficiency 
increased copper levels by 1.44 µg/g dry tissue (95% CI [+0.34 , +2.54] ; p = 0.002) and 3.45 
µg/g (95% CI [-0.42 , +7.32] ; p = 0.018) in maternal liver and placenta, respectively. In 
contrast, iron deficiency decreased copper levels in the fetal liver by 9.64 µg/g (95% CI [-15.85 
, -3.42], p = 0.006) (Figure 1A, Mann-Whitney), while zinc levels were increased by +81.6 
µg/g (95% CI [50.0 , 113.1], p < 0.0001). Zinc levels in maternal liver and placenta were not 
significantly altered by maternal iron deficiency (Figure 1B, T-test). Changes in absolute 
levels of iron, zinc and copper followed a similar pattern (Table 2), apart from the absolute zinc 
levels that were reduced by 4.08 µg (95% CI [-1.64 , -6.52] ; p = 0.003) in the fetal liver. 
 
3.2 Zinc and copper genes expression 
Maternal iron deficiency decreased the hepatic expression of the copper chaperones ATOX1 
by -10.5% (95% CI [-20.7 , -0.4] ; p = 0.042) and COX17 by -13.8% (95% CI [-25.3 , -2.3] ; p 
= 0.020) in the dams. In contrast, the hepatic expression of COX17 was increased by +15.0% 
(95% CI [+2.5 , +27.5] ; p = 0.020) in the fetus. In the placenta, iron deficiency led to a decrease 
in CCS, the chaperone that delivers Cu to SOD1, by -9.5% (95% CI [-18.0 , -1.0] ; p = 0.030) 
and CP by -15.0% (95% CI [-29.4 , -0.5] ; p = 0.042) expression (Figure 2). 
The maternal hepatic expression of the genes related to zinc metabolism were not affected by 
iron deficiency. In the placenta, ZIP4 was reduced by -23.7% (95%CI [-47.0 , -0.4] ; p = 0.047) 
and ZnT1 by -12.3% (95%CI [21.8 , -2.8] ; p = 0.012) in the iron deficient group compared to 
control (Figure 3). In fetal liver, iron deficiency also decreased ZIP4 by – 17.0% (95%CI [-
28.1 , -5.8] ; p = 0.004), while ZIP14 and ZnT1 were increased by +10.0% (95%CI [+0.7 , 
+19.3] ; p = 0.036) and by +18.7% (95%CI [+9.0 , +28.4] ; p = 0.0003), respectively (Figure 
3). 
The effect of maternal iron deficiency on copper and zinc metabolism observed in the current 
study is summarized in Table 3.  
4 Discussion 
In this paper, we have examined the interactions between iron, copper and zinc during 
pregnancy in the rat. The study has some limitations, in that the data can only be extrapolated 
to humans to a limited extent. However, given how well conserved micronutrient metabolism 
is between species, it is likely that the same results would be observed in humans with iron 
deficiency. We restricted our measurements to liver and placenta, as these are the major organs 
involved in micronutrient metabolism(3). Iron deficiency altered copper, but not zinc, 
concentrations in the maternal liver and placenta, confirming that the metabolism of copper is 
more sensitive to iron deficiency than that of zinc (15). However, maternal iron deficiency had 
an important impact on both copper and zinc levels in the fetal liver, which were reduced by 
~15% and augmented by ~25%, respectively.  
 
4.1 Effect of maternal iron deficiency on copper metabolism 
Maternal iron deficiency leads to the hepatic accumulation of copper in the dams, while copper 
levels are decreased in the fetal liver, as previously described by our group, as well as others 
(20, 21, 23). Interestingly, iron deficiency decreased the expression of the chaperones ATOX1 and 
COX17 in the maternal liver, contrasting with our previous findings, where no change in 
ATOX1 mRNA levels was observed (23). It is important to note that in our previous experiment, 
COX17 was not measured and ATOX1 was only measured in 6 samples. Further, the previous 
study used Northern blotting to detect expression levels, which is less sensitive than using RT-
PCR. The present study included 45 samples, which allows us to detect smaller changes with 
greater sensitivity. 
ATOX1 does not seem to be involved in copper uptake but is a copper chaperone which 
interacts with ATP7A and ATP7B and delivers copper to these pumps and hence to trans-Golgi 
network (36) or possibly the efflux pathway of the placenta (37). Moreover, ATOX1 appears 
essential to perinatal copper homeostasis (38) for synthesis of ceruloplasmin or export from the 
cell into the portal circulation (ATP7A in gut) or into the bile for excretion (ATP7B). 
Understandably, the inhibition of ATOX1 expression reduces the trafficking of ATPases (39), 
thus reducing copper export and causing its accumulation in the cell (40). Therefore, the small 
but significant reduction in ATOX1 expression in the iron deficient liver could be responsible 
– at least partially – for the increase in copper levels.  
 
In addition, the hepatic expression of COX17, a chaperone delivering Cu to the cytochrome 
oxidase complex in the respiratory chain, was also decreased. The impairment of mitochondrial 
function and the reduction of cytochrome c activity (which requires both iron and copper to 
function) is well established in iron deficient tissues, including in the liver (41, 42), though 
whether this is cause or consequence is not certain at this time. There are little data on the direct 
effects of copper on either ATOX1 or COX17 expression, so the possibility that these changes 
are a response to changes in copper levels, rather than copper levels being changed by the 
alterations in gene expression also cannot be excluded in these experiments 
 
As previously observed (23), maternal iron deficiency led to the increase of copper levels in the 
placenta (~19%), to a greater extent than the maternal liver (~10%). This was accompanied by 
the reduction of CCS expression, another chaperone channeling Cu for incorporation into the 
Cu-Zn superoxide dismutase (SOD) complex, an essential component of the anti-oxidant cell 
system. Copper has been shown to modulate the degradation of CCS (43) and copper 
supplementation in humans reduces CCS mRNA levels in peripheral mononuclear cells (44). It 
is likely that the downregulation of CCS expression observed here is due to the presence of 
elevated copper levels in the placenta, rather than a direct consequence of reduced iron levels. 
Our findings suggest that maternal iron deficiency leads to the impairment of SOD activity 
(closely related to CCS expression) and the anti-oxidant defense of the placenta, as observed 
in liver and brain cells upon copper accumulation (45, 46).  
 
Ceruloplasmin (CP) is involved in iron export in the liver, oxidizing Fe(II) to Fe(III) for 
incorporation into transferrin, while its homolog zyklopen performs the same function in 
placenta from mice and humans (47) . Whether the ferroxidase mRNA measured in the placenta 
is zyklopen, Cp or a combination of both remains uncertain, since the sequences are very 
similar and because the primers are from a commercial supplier. However it is likely that we 
measured the mRNA coding for a multicopper oxidase responsible for iron export (48) .  The 
effect that the reduced placental expression might have on iron transport is not clear, and 
contrasts with previous findings (48) . However, it is important to note that Cp protein and 
enzyme levels do not correlate with mRNA levels (49) and that changes in Cp mRNA expression 
observed in the present study may therefore have little physiological impact. Maternal iron 
deficiency is partly alleviated in the fetus, due to increased expression of transferrin receptors 
(50, 51), which would imply that ferroxidase expression or activity is not rate limiting.   
Copper transport across the placenta is less well understood. Copper appears to be taken up 
from the maternal circulation through CTR1 and excreted through ATPases (52, 53). It has been 
suggested that ATP7A is responsible for the efflux of copper from the basolateral membrane 
into the fetal circulation, while ATP7B is responsible for excreting copper back into the 
maternal circulation at the apical side (54). Whether ceruloplasmin and/or zyklopen are involved 
in copper efflux and/or delivery to the fetal liver, as we have previously (54) suggested for 
transport of copper from the mother to the placenta (55), and whether this could explain the 
differences observed in copper levels between placenta and fetal liver remains to be clarified.  
 
4.2 Effects of maternal iron deficiency on zinc metabolism 
The effect of iron deficiency on zinc metabolism in the pregnant rat is less marked than for 
copper but is nonetheless significant. Zinc levels in the maternal liver and placenta were not 
changed but were markedly increased in the fetal liver.  
In the maternal liver, the expression of the genes of zinc metabolism tested were unchanged, 
which is consistent with the lack of effect on zinc levels but contrasts with previous findings 
in male rats, where iron deficiency led to an increase in hepatic ZIP14 expression (19). It should 
be noted, however, that the authors also observed a small decrease in zinc levels which was not 
seen in the present study, nor in their other study of a similar design (19) . Taken together, these 
results imply that iron deficiency during pregnancy is unlikely to lead to changes in zinc 
metabolism that are physiologically important in the maternal liver. 
While zinc levels were unchanged in the placenta, ZIP4 and ZnT4, genes of zinc cellular uptake 
and exit, respectively, were both decreased in the placenta. The results do not fully match those 
seen in mice given a Zn deficient diet, where ZnT4, but also ZIP1, ZnT1, and 5 were reduced 
in placenta (33). It is possible that there was a mild reduction in zinc supply to and in efflux from 
the placenta, with a neutral net effect on zinc levels in the placenta. Zinc metabolism and 
transport in the placenta is still not entirely understood, and the role and localization of ZIP4 
in the placenta is not known. ZIP4 is crucial for zinc cellular uptake in the small intestine and 
is upregulated upon zinc deficiency in mice (56). It is also abundantly expressed in other tissues 
involved in nutrient absorption and reabsorption (stomach, colon, kidney) (57). While ZIP4 
expression could not be compared with intestinal or kidney expression in the present study, it 
is important to note that it was higher in the placenta compared to maternal liver (~2 fold) and 
fetal liver (~15 fold, data not shown). This suggests that the changes observed in placental 
expression could be biologically relevant, and further research is warranted to clarify the role 
of ZIP4 in placenta. If it were involved in the return of Zn from fetal to maternal circulation, 
then decreased expression could result in increased levels of Zn in the fetal liver. Interestingly, 
neither ZIP8 nor ZIP14, both of which have previously been implicated in iron metabolism as 
well as that of Zn (32), are altered in the placenta or maternal liver, which would argue against 
the changes in fetal liver Zn levels being a direct consequence of competition with iron for 
these transporters. 
Iron deficiency leads to an increase in zinc levels in the fetal liver, but also a lesser decrease in 
iron levels compared to the decrease observed in the maternal liver (58). Both these changes 
may be explained, at least partially, by an upregulation of ZIP14, which mediates the uptake 
of zinc, as well as non-transferrin-bound iron (31), and thus could help protect the fetus against 
iron deficiency. It is important to note that this does not rule out other mechanisms, such as an 
increased expression of transferrin receptors, as we have previously observed in the placenta 
of rats and women (50, 51). On the other hand, the reduced ZIP4 expression in the fetal liver is 
more likely to be a consequence of the increase in zinc levels, as has been seen in Zn overload 
in observed in the intestine and visceral yolk sac of mice (56). In addition, as described earlier 
in this discussion, ZIP4 expression in the fetal liver was fairly low compared to the other 
tissues, indicating that its changes may have little biological relevance. 
Contrasting with our results, ZnT1 hepatic upregulation has been reported in zinc deficient rats 
in association with zinc depletion in the liver (59), although this was only observed at the protein 
level. Whether the increase in ZnT1 mRNA expression in the fetal liver would lead to an 
increase in protein levels is uncertain, and whether this could lead to more zinc efflux back into 
the fetal circulation is unlikely in the present study. The reasons why ZnT1 upregulation is 
associated with a marked increase in zinc levels are not known and the role of ZnT1 in fetal 
liver zinc metabolism needs to be clarified.  
In summary, this study has shown that iron deficiency has opposite effects on copper and zinc 
levels in the fetal liver, and this is associated with changes in the expression of genes of copper 
and zinc metabolism in the placenta, as well as in the fetus. It is important to note that some of 
these effects may not be directly caused by iron deficiency, but rather by changes in the 
metabolism of the other two nutrients. The results further demonstrate that micronutrient 
metabolism, especially during pregnancy, is tightly interlinked and underscores the importance 
of considering all of the micronutrients when trying to alleviate deficiencies in one of them. It 
would be important to consider that the symptoms caused by deficiencies in one micronutrient 
(here iron) may not be caused directly by that deficiency, but by other deficiencies or overloads 
occurring as a consequence of the primary defect.  
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Tables 
Table 1: List of genes analysed by PCR using TaqMan® Gene Expression Assays 
(ThermoFisher Scientific) 
Gene Protein Assay ID 
ATOX1 Antioxidant 1 copper chaperone Rn00584459_m1     
COX17 Cytochrome c oxidase copper chaperone Rn00585530_m1 
CCS  Copper chaperone for superoxide dismutase Rn00584772_m1 
CP Ceruloplasmin Rn00561049_m1 
ATP7A ATPase copper transporting alpha (Menkes) Rn00583815_m1    
ATP7B ATPase copper transporting beta (Wilson) Rn00560862_m1 
SLC31A1 / CTR1 Copper transporter 1 Rn00683634_m1 
SLC39A1 / ZIP1 ZRT/IRT-like protein 1 Rn01458936_g1 
SLC39A4 / ZIP4 ZRT/IRT-like protein 4 Rn01505595_g1 
SLC39A8 / ZIP8  ZRT/IRT-like protein 8 Rn01748352_m1     
SLC39A14 / ZIP14 ZRT/IRT-like protein 14 Rn01468336_m1   
SLC30A1 / ZnT1 Zinc Transporter 1 Rn00575737_m1 
SLC30A4 / ZnT4 Zinc Transporter 4 Rn00597094_m1 
SLC30A5 / ZnT5 Zinc Transporter 5 Rn01493867_m1 
 
  
Table 2: Organ weight, water content and absolute iron, copper and zinc content in the 
maternal liver, placenta and fetal liver of control and iron deficient rats at d21 of 
gestation 
 
Control Iron deficient 
Maternal Liver 
  
    Organ weight (g)1 10.94 ± 0.39 11.60 ±  0.35 
    Water content (%)2 70.04 ± 0.26 71.22 ±  0.24** 
    Absolute iron content (mg)1 1.96 ± 0.29 0.70 ±  0.12†† 
    Absolute copper content (μg)1 44.77 ±  1.20 51.10 ±  1.48* 
    Absolute zinc content (μg)1 305.9 ±  8.2 326.8 ±  8.5 
Placenta 
  
    Organ weight (g) 3 0.512 ±  0.017 0.551 ±  0.009 
    Water content (%)2 87.83 ±  0.24 88.10 ±  0.27 
    Absolute iron content (mg)3 39.07 ±  1.88 28.47 ±  1.66*** 
    Absolute copper content (μg)3 1.17 ±  0.10 1.52 ±  0.09 
    Absolute zinc content (μg)3 5.52 ±  0.20 5.60 ±  0.19 
Fetal Liver 
  
    Organ weight (g)1 0.313 ±  0.009 0.234 ±  0.009*** 
    Water content (%)2 78.23 ±  0.21 79.26 ±  0.18* 
    Absolute iron content (mg)1 80.37 ±  2.38 20.08 ±  1.14††† 
    Absolute copper content (μg)1 3.62 ±  0.27 1.90 ±  0.15*** 
    Absolute zinc content (μg)1 23.37 ±  0.87 19.27 ±  0.85** 
 
1 n = 16 (8 control, 8 Fe deficient), 2 n = 54 (24 control, 30 Fe deficient), 3 n = 38 ; Data are 
mean ±  SEM; *, ** and *** indicate significant differences compared to control at p < 0.05, 
p < 0.01 and p < 0.05 (independent t-test), †† and ††† indicate significant differences compared 
to control at p < 0.01 and p < 0.01 (Mann-Whitney U test). 
 
  
Table 3: Summary of the effect of maternal iron deficiency on copper and zinc 
metabolism in maternal liver, placenta and fetal liver at d21 of pregnancy  
 
Gene Maternal Liver Placenta Fetal Liver 
Cu1 ↑↑ ↑ ↓ 
ATOX12 ↓ = = 
COX172 ↓ = ↑ 
CCS 2 = ↓ = 
CP2 = ↓ = 
ATP7A2 = = = 
ATP7B2 = = = 
CTR12 = = = 
Zn1 = = ↑↑ 
ZIP12 = = = 
ZIP42 = ↓ ↓ 
ZIP82 = = = 
ZIP142 = = ↑ 
ZnT12 = = ↑ 
ZnT42 = ↓ = 
ZnT52 = = = 
The concentrations of copper, zinc, and the expression of genes of copper and zinc metabolism 
were either greatly increased (↑↑), increased (↑), decreased (↓) or unchanged (=) by maternal 
iron deficiency. 1 n = 54 (control n = 24, iron deficient n = 30); 2 n = 45 (control n = 21, iron 
deficient n = 24). 
 
 
  
Figure Legends: 
 
Figure 1: The effect of maternal iron deficiency on copper (A) and zinc (B) levels in 
maternal liver, placenta and fetal liver 21d after mating (n = 54) 
Data are expressed as mean percentage of control and error bars are SEM. Results are 
significantly different between the control (Ctrl, n = 24) and iron deficient (Fe Def, n= 30) 
groups at P < 0.0001 (****)  (independent t-test), < 0.01 (††) and < 0.05 (†) (Mann-Whitney 
test). 
 
Figure 2: The effect of maternal iron deficiency on the expression of genes related to 
copper metabolism (n=45) 21d after mating 
Data are expressed as mean percentage of control and error bars are SEM. * Results are 
significantly different between the control (Ctrl, n = 21) and iron deficient (Fe Def, n = 24) 
groups at P <  0.05 (Mann-Whitney test). 
Abbreviations: Antioxidant 1 copper chaperone (ATOX1), cytochrome c oxidase chaperone 
(COX17), ATPase copper transporting alpha (Menkes) (ATP7A), ATPase copper transporting 
beta (Wilson) (ATP7B); copper chaperone for superoxide dismutase (CCS), ceruloplasmin 
(CP), copper transporter 1 (CTR1). 
 
Figure 3: The effect of maternal iron deficiency on the expression of genes related to 
copper metabolism (n=45) 21d after mating 
Data are expressed as mean percentage of control and error bars are SEM. Results are 
significantly different between the control (Ctrl, n = 21) and iron deficient (Fe Def, n = 24) 
groups at P <  0.01 (**) and < 0.05 (*) (Mann-Whitney test). 
Abbreviations: ZRT/IRT-like protein 1 (ZIP1), ZRT/IRT-like protein 4 (ZIP4), ZRT/IRT-like 
protein (ZIP8), ZRT/IRT-like protein 14 (ZIP14), Zinc Transporter 1 (ZnT1), Zinc Transporter 
4 (ZnT4), Zinc Transporter 5 (ZnT5). 
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Figure 1: A - Effect of maternal iron deficiency on 
copper levels
B - Effect of maternal iron deficiency on zinc levels
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